EHealth Historical Financial Ratios
| EHTH Stock | USD 8.32 0.04 0.48% |
EHealth is recently reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 0.26 or Days Sales Outstanding of 780 will help investors to properly organize and evaluate eHealth financial condition quickly.
EHealth |
About EHealth Financial Ratios Analysis
eHealthFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate EHealth investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on EHealth financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across EHealth history.
EHealth Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing eHealth stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on EHealth sales, a figure that is much harder to manipulate than other eHealth multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Roic
Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.Research And Ddevelopement To Revenue
The ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most ratios from EHealth's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into eHealth current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.As of now, EHealth's Sales General And Administrative To Revenue is decreasing as compared to previous years. The EHealth's current Research And Ddevelopement To Revenue is estimated to increase to 0.18, while Price To Sales Ratio is projected to decrease to 0.51.
| 2023 | 2024 (projected) | Dividend Yield | 0.013 | 0.0116 | Price To Sales Ratio | 0.54 | 0.51 |
EHealth fundamentals Correlations
Click cells to compare fundamentals
EHealth Account Relationship Matchups
High Positive Relationship
High Negative Relationship
EHealth fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 4.38 | 3.15 | 1.27 | 0.33 | 0.54 | 0.51 | |
| Ptb Ratio | 4.21 | 2.19 | 0.7 | 0.14 | 0.27 | 0.26 | |
| Days Sales Outstanding | 127.52 | 138.39 | 176.72 | 220.95 | 743.24 | 780.4 | |
| Book Value Per Share | 22.85 | 32.18 | 36.67 | 33.42 | 32.27 | 33.88 | |
| Free Cash Flow Yield | (0.0399) | (0.0716) | (0.27) | (0.32) | (0.0715) | (0.0679) | |
| Operating Cash Flow Per Share | (3.1) | (4.14) | (6.07) | (0.98) | (0.24) | (0.25) | |
| Stock Based Compensation To Revenue | 0.0446 | 0.0432 | 0.061 | 0.0501 | 0.0513 | 0.0319 | |
| Capex To Depreciation | 1.88 | 1.84 | 1.11 | 0.73 | 0.54 | 0.88 | |
| Pb Ratio | 4.21 | 2.19 | 0.7 | 0.14 | 0.27 | 0.26 | |
| Ev To Sales | 4.41 | 3.16 | 1.19 | 0.23 | 0.51 | 0.49 | |
| Free Cash Flow Per Share | (3.83) | (5.06) | (6.85) | (1.55) | (0.62) | (0.65) | |
| Roic | 0.2 | 0.0533 | (0.063) | (0.0702) | (0.0274) | (0.026) | |
| Inventory Turnover | 0.35 | 0.5 | 0.25 | 0.0871 | 0.1 | 0.0952 | |
| Net Income Per Share | 2.9 | 1.75 | (3.9) | (3.24) | (1.01) | (0.96) | |
| Days Of Inventory On Hand | 726.67 | 1.4K | 4.2K | 2.22E-4 | 1.99E-4 | 1.89E-4 | |
| Capex To Revenue | 0.0333 | 0.0408 | 0.0388 | 0.0383 | 0.0238 | 0.024 | |
| Cash Per Share | 1.02 | 3.59 | 4.6 | 5.28 | 4.34 | 4.82 | |
| Pocfratio | (31.01) | (17.04) | (4.2) | (4.93) | (36.51) | (34.68) | |
| Capex To Operating Cash Flow | (0.24) | (0.22) | (0.13) | (0.58) | (1.61) | (1.53) | |
| Pfcf Ratio | (25.09) | (13.96) | (3.72) | (3.12) | (13.98) | (13.28) | |
| Days Payables Outstanding | 3.3K | 3.3K | 2.5K | 1.5K | 1.5K | 839.33 | |
| Income Quality | (1.07) | (2.37) | 1.56 | 0.3 | 0.24 | 0.25 | |
| Roe | 0.13 | 0.0543 | (0.11) | (0.097) | (0.0312) | (0.0296) | |
| Ev To Operating Cash Flow | (31.23) | (17.06) | (3.95) | (3.53) | (34.63) | (32.9) | |
| Pe Ratio | 33.15 | 40.43 | (6.54) | (1.49) | (8.66) | (8.23) | |
| Return On Tangible Assets | 0.0967 | 0.0459 | (0.091) | (0.0821) | (0.0259) | (0.0272) | |
| Ev To Free Cash Flow | (25.27) | (13.98) | (3.5) | (2.24) | (13.26) | (12.6) | |
| Earnings Yield | 0.0302 | 0.0247 | (0.15) | (0.67) | (0.12) | (0.11) | |
| Intangibles To Total Assets | 0.0678 | 0.0469 | 0.001673 | 0.0281 | 0.0212 | 0.0344 | |
| Net Debt To E B I T D A | 0.14 | 0.0423 | 0.39 | 0.89 | 1.37 | 1.44 | |
| Current Ratio | 1.84 | 3.92 | 5.4 | 6.62 | 4.87 | 6.36 | |
| Tangible Book Value Per Share | 20.67 | 30.31 | 36.6 | 32.27 | 31.43 | 33.0 | |
| Receivables Turnover | 2.86 | 2.64 | 2.07 | 1.65 | 0.49 | 0.47 | |
| Graham Number | 38.6 | 35.56 | 56.71 | 49.38 | 27.04 | 14.75 | |
| Shareholders Equity Per Share | 22.85 | 32.18 | 36.67 | 33.42 | 32.27 | 33.88 | |
| Debt To Equity | 0.009028 | 0.006199 | 0.005644 | 0.0794 | 0.0828 | 0.0869 | |
| Capex Per Share | 0.53 | 0.73 | 0.91 | 0.78 | 0.57 | 0.28 |
Currently Active Assets on Macroaxis
When determining whether eHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ehealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ehealth Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EHealth. If investors know EHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.108 | Earnings Share (2.62) | Revenue Per Share 16.016 | Quarterly Revenue Growth (0.1) | Return On Assets (0.01) |
The market value of eHealth is measured differently than its book value, which is the value of EHealth that is recorded on the company's balance sheet. Investors also form their own opinion of EHealth's value that differs from its market value or its book value, called intrinsic value, which is EHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EHealth's market value can be influenced by many factors that don't directly affect EHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if EHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.